Correction of Fragile X Syndrome in Mice

[1]  Gerald M Edelman,et al.  Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Stryker,et al.  Rapid Ocular Dominance Plasticity Requires Cortical but Not Geniculate Protein Synthesis , 2002, Neuron.

[4]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[5]  I. Weiler,et al.  Metabotropic glutamate receptors trigger postsynaptic protein synthesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Bear,et al.  Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. , 2000, Science.

[7]  P. Bergold,et al.  Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges. , 1998, Journal of neurophysiology.

[8]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[9]  K. Hsu,et al.  The Group I Metabotropic Glutamate Receptor Agonist (S)-3,5-Dihydroxyphenylglycine Induces a Novel Form of Depotentiation in the CA1 Region of the Hippocampus , 2002, The Journal of Neuroscience.

[10]  Guy Nagels,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[11]  J. Darnell,et al.  Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.

[12]  A. Faden,et al.  Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. , 2006, CNS drug reviews.

[13]  H. Schiöth,et al.  The Phylogenetic Relationship of the Glutamate and Pheromone G‐Protein‐Coupled Receptors in Different Vertebrate Species , 2005, Annals of the New York Academy of Sciences.

[14]  Wim E Crusio,et al.  Fmr1 KO Mice as a Possible Model of Autistic Features , 2006, TheScientificWorldJournal.

[15]  A. Newman,et al.  Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists. , 2007, Bioorganic & medicinal chemistry letters.

[16]  Michael Lardelli,et al.  Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. , 2006, Human molecular genetics.

[17]  I. Weiler,et al.  Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond , 2006, The Journal of Neuroscience.

[18]  Richard Paylor,et al.  Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.

[19]  E. De Schutter,et al.  Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.

[20]  M. Bear,et al.  Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. , 2001, Journal of neurophysiology.

[21]  D. Nelson,et al.  (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. , 2000, Human molecular genetics.

[22]  J. Roder,et al.  Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. , 1998, Learning & memory.

[23]  C. B. Smith,et al.  Postadolescent Changes in Regional Cerebral Protein Synthesis: An In Vivo Study in the Fmr1 Null Mouse , 2005, The Journal of Neuroscience.

[24]  R. Wong,et al.  Prolonged Epileptiform Discharges Induced by Altered Group I Metabotropic Glutamate Receptor-Mediated Synaptic Responses in Hippocampal Slices of a Fragile X Mouse Model , 2005, The Journal of Neuroscience.

[25]  Jonathan R. Whitlock,et al.  Learning Induces Long-Term Potentiation in the Hippocampus , 2006, Science.

[26]  J. D. McGaugh,et al.  Anisomycin infused into the hippocampus fails to block "reconsolidation" but impairs extinction: the role of re-exposure duration. , 2006, Learning & memory.

[27]  D. Loesch,et al.  Growth in stature in fragile X families: a mixed longitudinal study. , 1995, American journal of medical genetics.

[28]  J. Roder,et al.  Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP , 1997, The Journal of Neuroscience.

[29]  M. Bear,et al.  Fragile X: Translation in Action , 2008, Neuropsychopharmacology.

[30]  Susumu Tonegawa,et al.  Altered Cortical Synaptic Morphology and Impaired Memory Consolidation in Forebrain- Specific Dominant-Negative PAK Transgenic Mice , 2004, Neuron.

[31]  W. Abraham,et al.  Metabotropic Glutamate Receptors Trigger Homosynaptic Protein Synthesis to Prolong Long-Term Potentiation , 2000, The Journal of Neuroscience.

[32]  H. Robertson Audiogenic seizures: increased benzodiazepin receptor binding in a susceptible strain of mice. , 1980, European journal of pharmacology.

[33]  M. Ito,et al.  Induction of long-term depression in cerebellar Purkinje cells requires a rapidly turned over protein. , 2001, Journal of neurophysiology.

[34]  Mark F. Bear,et al.  How Monocular Deprivation Shifts Ocular Dominance in Visual Cortex of Young Mice , 2004, Neuron.

[35]  M. Bear,et al.  A biochemical correlate of the critical period for synaptic modification in the visual cortex. , 1989, Science.

[36]  Mark F Bear,et al.  The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.

[37]  D. Condorelli,et al.  Expression of metabotropic glutamate receptors in the rat and human testis. , 2001, The Journal of endocrinology.

[38]  C. Heidbreder,et al.  Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo , 2003, Synapse.